Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome.
Authors: Espinosa-López E M, Ortiz-Guisado B, Diez de Castro E, Durham A, Aguilera-Tejero E, Gómez-Baena G
Journal: BMC veterinary research
Summary
# Editorial Summary Equine Metabolic Syndrome presents a significant diagnostic challenge in practice, as current methods for identifying insulin dysregulation—the hallmark feature—are hampered by poor sensitivity, repeatability issues, and confounding variables including diet, stress, and season. Researchers used quantitative proteomics to analyse plasma samples from horses with EMS (n=20), insulin-dysregulated horses without clinical signs (n=20), and healthy controls (n=20), identifying protein biomarkers that could improve early detection and elucidate the underlying pathophysiological mechanisms. The study revealed distinct plasma protein signatures associated with EMS and insulin dysregulation, highlighting alterations in metabolic, inflammatory, and immune-related pathways that extend beyond simple hyperinsulinaemia. These findings suggest that multi-marker proteomic panels could offer superior diagnostic specificity compared to single insulin measurements, potentially enabling earlier intervention before laminitic episodes occur. For farriers, veterinarians, and nutritionists managing at-risk horses, validated proteomic biomarkers could transform case identification from reliance on clinical history and inconsistent laboratory tests to objective, robust markers of metabolic dysfunction—ultimately reducing the preventable complications that threaten equine welfare.
Read the full abstract on PubMed
Practical Takeaways
- •Current EMS diagnosis relies on limited tools (basal insulin, OST); new plasma biomarkers may offer more reliable detection in field settings
- •Understanding EMS pathophysiology at the protein level may lead to better preventive strategies and earlier intervention before laminitis develops
- •Consider that multiple factors (diet, age, stress, season, medications) affect insulin testing—new biomarkers could provide more consistent results
Key Findings
- •Quantitative proteomics identified potential plasma biomarkers for EMS beyond traditional insulin measurements
- •Study reveals pathophysiological mechanisms underlying equine metabolic syndrome through protein analysis
- •Current diagnostic methods (basal insulin, oral sugar test) have limitations in sensitivity and repeatability for EMS detection
- •Early detection biomarkers could prevent laminitis and associated complications in horses with EMS